Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/1993
10/20/1993EP0565896A2 Derivatives of aspartic acid, preparation and use thereof
10/20/1993EP0565621A1 Method of making camptothecin and camptothecin analogs
10/20/1993EP0413692B1 Use of hexatriene derivatives for the manufacture of preparations for treating acne, psoriasis and light-induced damage to the skin
10/20/1993EP0398925B1 Growth inhibiting agent and the use thereof
10/19/1993US5254582 Antitumor compositions and methods
10/19/1993US5254544 Anticholesterol
10/19/1993CA1323374C 2 - furylbutyrolactones
10/19/1993CA1323366C (1h-imidazol-1-ylmethyl) substituted benzimidazole derivatives
10/19/1993CA1323306C Pharmacological agent-lipid solution preparation
10/19/1993CA1323303C Advanced anticancer therapy and cytotoxic medicaments for its implementation
10/15/1993CA2093866A1 Methods of inhibiting the growth of multidrug resistant tumors
10/14/1993WO1993020439A1 Compositions and methods for regulating cellular signal transducing systems
10/14/1993WO1993020197A1 Stem cell proliferation factor
10/14/1993WO1993020186A1 In vitro generation of human dendritic cells and uses thereof
10/14/1993WO1993020101A1 Inhibitor of protein kinase c
10/14/1993WO1993020097A1 17-substituted steroids useful in cancer treatment
10/14/1993WO1993020095A1 Antisense oligonucleotide inhibition of papillomavirus
10/14/1993WO1993020078A1 Pharmaceutically active bicyclic-heterocyclic amines
10/14/1993WO1993020056A1 Melamine derivatives for use in the treatment of cancer
10/14/1993WO1993020055A1 Antiproliferative quinazolines
10/14/1993WO1993020047A1 Hydroxamic acid based collagenase and cytokine inhibitors
10/14/1993WO1993019782A1 Specific detection of cell surface receptor leukocyte adhesion molecule-1
10/14/1993WO1993019761A1 Lipid-a analogs: new monosaccharide and disaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activities
10/14/1993WO1993019760A1 Method for inhibition of cell motility by sphingosine-1-phosphate, its derivatives and mimetics and method of synthesizing sphingosine-1-phosphate and its derivatives
10/14/1993WO1993019746A1 Topical administration of toremifene and its metabolites
10/14/1993WO1993019668A1 Method and kit for imaging and treating organs and tissues
10/14/1993WO1993019605A1 Evaluation and treatment of patients with progressive immunosuppression
10/14/1993WO1993019591A1 Methods and compositions for gene, tumor, and viral infection therapy, and prevention of programmed cell death (apoptosis)
10/14/1993WO1992008456A3 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated
10/14/1993CA2132624A1 Compositions and methods for regulating cellular signal transducing systems
10/14/1993CA2130992A1 Method for inhibition of cell motility by sphingosine-1-phosphate, its derivatives and mimetics and method of synthesizing sphingosine-1-phosphate and its derivatives
10/14/1993CA2130937A1 Pharmaceutically active bicyclic-heterocyclic amines
10/14/1993CA2126341A1 Lipid-a analogs: new monosaccharide and dissaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activities
10/13/1993EP0565449A1 Rhenium and Technetium labelling of hormones
10/13/1993EP0565059A1 Indole derivative
10/13/1993EP0564561A1 Peptides ketoamides, ketoacids, and ketoesters
10/13/1993EP0458886B1 Agents for diagnosing and treating melanomas, aromatic halogenated derivatives usable as such agents and their preparation
10/13/1993EP0431076B1 Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers
10/12/1993US5252720 Metal complexes of water soluble texaphyrins
10/12/1993US5252673 Reaction product of divinyl ether-maleic anhydride copolymer, an aminoacid and mitomycin C; antitumor agents, anticarcino-genic
10/12/1993US5252560 Cyclic imide derivatives, compositions and use
10/12/1993US5252479 Safe vector for gene therapy
10/12/1993US5252477 Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation
10/12/1993US5252344 Hardening agent for affected tissues of the digestive system
10/08/1993CA2093304A1 Indole derivative
10/06/1993EP0564409A1 Pyrimidin derivatives and process for their preparation
10/06/1993EP0564121A2 Formulation for the treatment of cancer comprising a bacterial extract
10/06/1993EP0563714A2 TNF-Muteins
10/06/1993EP0563627A2 Anti-tumor method and anti-tumor agent
10/06/1993EP0563485A1 In vitro generation of human dendritic cells and uses thereof
10/06/1993EP0563475A1 Cell binding agent conjugates of derivatives of CC-1065
10/06/1993EP0563307A1 Medicaments for the treatment of papillomavirus diseases
10/06/1993EP0563278A1 Control of gene expression by ionizing radiation
10/06/1993EP0563209A1 Use of hirudine and its muteines and their peg derivatives for the combined treatment of tumours
10/06/1993EP0563198A1 TARGETTING IgE EFFECTOR CELLS TO TUMOR CELLS
10/06/1993EP0563177A1 Oral administration of alpha interferon to treat lung malignancies
10/06/1993EP0563060A1 Synergism of tnf and il-4
10/06/1993CN1022322C Condensed pyrazole 3-oxo-propanenitrile derivatives and process for their prepn.
10/05/1993US5250722 Taxane derivatives, their preparation and use in oncology
10/05/1993US5250683 Anticarcinogenic agents
10/05/1993US5250549 Antitumor agents
10/05/1993CA1322723C Inhibitors for replication of retroviruses and for the expression of oncogene products
10/05/1993CA1322720C Anticarcinogenic agents
10/05/1993CA1322713C Compositions and methods for modulating the effect of tnf and il-1
10/03/1993CA2091313A1 Tnf-muteins
09/1993
09/30/1993WO1993019203A1 Oligonucleotide modulation of protein kinase c
09/30/1993WO1993019196A1 ANTI-CD3 AGLYCOSYLATED IgG ANTIBODY
09/30/1993WO1993019191A1 Defective recombinant adenoviruses expressing cytokines for use in antitumoral treatment
09/30/1993WO1993019183A1 Immunization by inoculatioon of dna transcription unit
09/30/1993WO1993019180A1 Genetically engineered antibodies
09/30/1993WO1993019179A1 Ifn receptors recognition factors, protein sequences and methods of use thereof
09/30/1993WO1993019176A1 Leucine zippers
09/30/1993WO1993019094A1 A monoclonal antibody to a human mdr1 multidrug resistance gene product, and uses
09/30/1993WO1993019051A1 Dipeptidylquinazolones as anti-cancer agents
09/30/1993WO1993019044A1 Novel vitamin d analogues
09/30/1993WO1993019037A1 Compounds
09/30/1993WO1993018797A1 Method of intraoperatively detecting and locating tumoral tissues
09/30/1993WO1993018653A1 Methods of achieving antileukemia activity using 16-membered-macrolide-type compounds
09/30/1993WO1993018652A1 Methods of achieving antitumor activity using 16-membered-macrolide-type compounds
09/30/1993WO1993018651A1 Cyclic anti-tumor promoter compounds, compositions and methods for production and use
09/30/1993WO1993016185A3 Biosynthetic binding protein for cancer marker
09/30/1993WO1993015203A3 Polypeptides with fibronectin binding sites as modulators for matrix assembly
09/30/1993CA2132319A1 Cyclic anti-tumor promoter compounds, compositions and methods for production and use
09/30/1993CA2132317A1 Ifn receptors recognition factors, protein sequences and methods of use thereof
09/30/1993CA2132310A1 Methods of achieving antileukemia activity using 16-membered macrolide-type compounds
09/30/1993CA2132094A1 Oligonucleotide modulation of protein kinase c
09/30/1993CA2131315A1 Method of intraoperatively detecting and locating tumoral tissues
09/30/1993CA2130173A1 Genetically engineered antibodies
09/30/1993CA2120703A1 Novel vitamin d analogues
09/29/1993EP0562734A1 Anti-tumour compounds containing quinazoline and tetrazole rings
09/29/1993EP0562641A1 Dehydrated liposomes
09/29/1993EP0561960A1 Leukemia inhibitory factor receptors
09/29/1993EP0382781B1 Composition for treating cancers characterized by over-expression of the c-fms proto-oncogene
09/29/1993EP0380623B1 Irreversible peptide ligands for bombesin receptors
09/29/1993CN1076696A Pharmaceutical compounds
09/29/1993CN1076695A Baccatine iii derivatives
09/29/1993CN1076613A Elemene emulsion injection and its preparing process
09/29/1993CN1022248C Novel 2'-halomethylidene, uridine and guanosine drivatives
09/28/1993US5248697 For treatment of radiation associated oxidative damage in tissue
09/28/1993US5248691 Furanoindolines
1 ... 2122 2123 2124 2125 2126 2127 2128 2129 2130 2131 2132 2133 2134 2135 2136 2137 2138 2139 2140 2141 2142 ... 2211